Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received October 18, 2020
- Revision received January 1, 2021
- Accepted January 5, 2021
- Published online January 30, 2021.
Copyright & Usage
Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Author Information
- HIDEYUKI KINOSHITA1⇑,
- TSUKASA YONEMOTO1,
- HIROTO KAMODA1,
- YOKO HAGIWARA1,
- TOSHINORI TSUKANISHI1,
- MASAHIRO INOUE2,
- FUMIHIDE TERAKAWA3,
- SEIJI OHTORI3 and
- TAKESHI ISHII1
- 1Department of Orthopedic Surgery, Chiba Cancer Center, Chiba, Japan;
- 2Department of Orthopaedic Surgery, Eastern Chiba Medical Center, Chiba, Japan;
- 3Department of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan
- Correspondence to: Hideyuki Kinoshita, Department of Orthopedic Surgery, Chiba Cancer Center, 666-2 Nitonacho, Chuo-ku, Chiba 260-8717, Japan. Tel: +81 432645431, Fax: +81 432628680, e-mail: kinoshi1783{at}yahoo.co.jp
Statistics from Altmetric.com
Cited By...
In this issue
Jump to section
Related Articles
Cited By...
- Effectiveness of Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcoma in Older Patients
- Thioredoxin Reductase Inhibitor Suppresses the Local Progression of Rhabdomyosarcoma With PDX Models
- Combined Auranofin and Celecoxib Suppresses the Local Progression and Pulmonary Metastases of Osteosarcoma In Vivo
- Clavicula Pro Humero Reconstruction for Malignant Tumor of the Proximal Humerus in Children and Adults
- Doxorubicin Combined With Ifosfamide for Sarcoma Induces Muscle Atrophy and Sleep Disruption
- The Thioredoxin-1 Inhibitor, PX-12, Suppresses Local Osteosarcoma Progression
- The Thioredoxin Reductase Inhibitor Auranofin Suppresses Pulmonary Metastasis of Osteosarcoma, But Not Local Progression
- Poor Efficacy of Postoperative Radiotherapy in Infiltrative High-grade Soft Tissue Sarcomas